Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells.

Flagler K, Alexeev V, Pierce EA, Igoucheva O.

Gene Ther. 2008 Jul;15(14):1035-48. doi: 10.1038/gt.2008.31. Epub 2008 Mar 13.

PMID:
18337839
2.

Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy.

DiMatteo D, Callahan S, Kmiec EB.

Exp Cell Res. 2008 Feb 15;314(4):878-86. Epub 2007 Oct 24.

PMID:
18078930
3.

Progress and prospects: targeted gene alteration (TGA).

Parekh-Olmedo H, Kmiec EB.

Gene Ther. 2007 Dec;14(24):1675-80. Epub 2007 Nov 1. Review.

PMID:
17972921
4.

Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors.

Boutet SC, Disatnik MH, Chan LS, Iori K, Rando TA.

Cell. 2007 Jul 27;130(2):349-62.

5.
6.

Targeted chromosomal gene modification in human cells by single-stranded oligodeoxynucleotides in the presence of a DNA double-strand break.

Radecke F, Peter I, Radecke S, Gellhaus K, Schwarz K, Cathomen T.

Mol Ther. 2006 Dec;14(6):798-808. Epub 2006 Aug 14.

PMID:
16904944
7.

Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.

Bertoni C, Jarrahian S, Wheeler TM, Li Y, Olivares EC, Calos MP, Rando TA.

Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):419-24. Epub 2005 Dec 30.

8.

Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs.

Andrieu-Soler C, Casas M, Faussat AM, Gandolphe C, Doat M, Tempé D, Giovannangeli C, Behar-Cohen F, Concordet JP.

Nucleic Acids Res. 2005 Jul 7;33(12):3733-42. Print 2005.

9.

Mouse retina has oligonucleotide-induced gene repair activity.

Ciavatta VT, Padove SA, Boatright JH, Nickerson JM.

Invest Ophthalmol Vis Sci. 2005 Jul;46(7):2291-9.

PMID:
15980213
10.

Strand bias in oligonucleotide-mediated dystrophin gene editing.

Bertoni C, Morris GE, Rando TA.

Hum Mol Genet. 2005 Jan 15;14(2):221-33. Epub 2004 Nov 24.

11.

Site-specific strand bias in gene correction using single-stranded oligonucleotides.

Sørensen CB, Krogsdam AM, Andersen MS, Kristiansen K, Bolund L, Jensen TG.

J Mol Med (Berl). 2005 Jan;83(1):39-49. Epub 2004 Oct 27. Erratum in: J Mol Med. 2005 Jun;83(6):495-6.

PMID:
15517130
13.

Enhanced oligonucleotide-directed gene targeting in mammalian cells following treatment with DNA damaging agents.

Ferrara L, Parekh-Olmedo H, Kmiec EB.

Exp Cell Res. 2004 Oct 15;300(1):170-9.

PMID:
15383324
14.

Chromosomal site-specific double-strand breaks are efficiently targeted for repair by oligonucleotides in yeast.

Storici F, Durham CL, Gordenin DA, Resnick MA.

Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14994-9. Epub 2003 Nov 20.

15.

Branched oligonucleotides induce in vivo gene conversion of a mutated EGFP reporter.

Olsen PA, McKeen C, Krauss S.

Gene Ther. 2003 Oct;10(21):1830-40.

PMID:
12960973
16.

Restoration of dystrophin expression in mdx muscle cells by chimeraplast-mediated exon skipping.

Bertoni C, Lau C, Rando TA.

Hum Mol Genet. 2003 May 15;12(10):1087-99.

17.
18.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk